Rockefeller Capital Management
IMGN

Rockefeller Capital Management’s Immunogen Inc IMGN Stock Holding History

Rockefeller Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-631
Closed -$3K – 4089
2022
Q4 		$3K Hold
631
– – ﹤0.01% 3515
2022
Q3 		$3K Buy
631
+178
+39% +$938 ﹤0.01% 3531
2022
Q2 		$2K Sell
453
-993
-69% -$4.31K ﹤0.01% 3866
2022
Q1 		$6K Buy
1,446
+192
+15% +$1.06K ﹤0.01% 3301
2021
Q4 		$9K Buy
1,254
+756
+152% +$4.7K ﹤0.01% 3050
2021
Q3 		$2K Sell
498
-168
-25% -$971 ﹤0.01% 3502
2021
Q2 		$4K Buy
666
+35
+6% +$244 ﹤0.01% 3123
2021
Q1 		$5K Buy
631
+253
+67% +$2.07K ﹤0.01% 2918
2020
Q4 		$2K Sell
378
-21
-5% -$122 ﹤0.01% 2682
2020
Q3 		$1K Sell
399
-3
-0.7% -$12 ﹤0.01% 2550
2020
Q2 		$2K Buy
402
+6
+2% +$26 ﹤0.01% 2387
2020
Q1 		$1K Sell
396
-385
-49% -$1.68K ﹤0.01% 2329
2019
Q4 		$4K Sell
781
-109
-12% -$370 ﹤0.01% 1843
2019
Q3 		$2K Sell
890
-101
-10% -$268 ﹤0.01% 1815
2019
Q2 		$2K Sell
991
-4,817
-83% -$11.4K ﹤0.01% 1567
2019
Q1 		$16K Buy
+5,808
New +$25.2K ﹤0.01% 1341

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rockefeller Capital Management's IMGN Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Immunogen Inc (IMGN) in Q1 2023, closing a stake of 631 shares — an estimated $3K sold.

Rockefeller Capital Management first reported a position in IMGN in Q1 2019 and held it in 16 quarters. The position peaked at $16K in Q1 2019. 190 funds tracked by Wall St. Rank hold IMGN as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Immunogen Inc position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 631 Immunogen Inc shares in Q1 2023, an estimated $3K.
  • Rockefeller Capital Management first reported a position in Immunogen Inc in Q1 2019 and held it in 16 quarters.
  • Rockefeller Capital Management's Immunogen Inc position peaked at $16K in Q1 2019.
  • 190 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.